top of page
Latest News
Reducing barriers to biologic access may help more people with severe asthma achieve remission
Ecological analysis links easier access to biologic therapies with better asthma outcomes, including clinical remission Building on the GLEAM I study linking earlier identification and treatment of high-risk and severe asthma with greater likelihood of remission, the GLEAM II study reveals that patients in countries with fewer barriers to biologic access were significantly more likely to achieve clinical remission and other favourable asthma outcomes than those in countries w
Aug 103 min read
bottom of page